Bronchicine CAe Canine Tracheobronchitis Vaccine
برونكيسين سي إيه إي لقاح السعال الديكي في الكلاب مستخلص أنتيجين خلوي
Bronchicine CAe is a cellular antigen extract of Bordetella bronchiseptica for the vaccination of healthy dogs 8 weeks of age or older as an aid in the control of canine infectious tracheobronchitis (kennel cough) caused by Bordetella bronchiseptica. Prepared by non-covalent subunit extraction technology to maximize antigenicity and safety.
Dosage Form
Injection
Product Type
Biological
Manufacturer
Package
Cartons of 25 x 1-dose vials (1 mL each)
Dosages
| Species | Dosage | Route | Duration |
|---|---|---|---|
| Dog | 1 mL administered subcutaneously | Subcutaneous (SC) | Initial series of 2 doses administered 2 to 4 weeks apart; revaccinate annually |
Withdrawal Periods
No withdrawal information available.
Indications
-
Vaccination of healthy dogs 8 weeks of age or older as an aid in the control of canine infectious tracheobronchitis (kennel cough) caused by Bordetella bronchiseptica.
Contraindications
-
Do not vaccinate clinically ill or debilitated dogs.
Precautions
-
Contains thimerosal and gentamicin as preservatives. As with any vaccine, anaphylactoid reactions may occur; administer epinephrine or equivalent supportive care.
Side Effects
-
Transient local swelling or mild tenderness at the injection site may occasionally occur.
Images
Documents
-
Download
Bronchicine CAe Canine Tracheobronchitis Vaccine Prescribing Information
Leaflet
Active Ingredients
Diseases
No diseases linked.
Related Products
No data available
Information has not been added yet.
Related Products By Active Ingredient
No data available
Information has not been added yet.
Companies
-
Zoetis
Manufacturer
Alternatives
No alternatives available.